| 标题 |
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Min Yan; Quchang Ouyang; Tao Sun; Limin Niu; Jin Yang; et al 出版日期:2022-01-31 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)